» Articles » PMID: 11558796

Transected Neurites, Apoptotic Neurons, and Reduced Inflammation in Cortical Multiple Sclerosis Lesions

Overview
Journal Ann Neurol
Specialty Neurology
Date 2001 Sep 18
PMID 11558796
Citations 476
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system that causes motor, sensory, and cognitive deficits. The present study characterized demyelinated lesions in the cerebral cortex of MS patients. One hundred twelve cortical lesions were identified in 110 tissue blocks from 50 MS patients. Three patterns of cortical demyelination were identified: Type I lesions were contiguous with subcortical white matter lesions; Type II lesions were small, confined to the cortex, and often perivascular; Type III lesions extended from the pial surface to cortical layer 3 or 4. Inflammation and neuronal pathology were studied in tissue from 8 and 7 patients, respectively. Compared to white matter lesions, cortical lesions contained 13 times fewer CD3-positive lymphocytes (195 vs 2,596/mm3 of tissue) and 6 times fewer CD68-positive microglia/macrophages (11,948 vs 67,956/mm3 of tissue). Transected neurites (both axons and dendrites) occurred at a density of 4,119/mm3 in active cortical lesions, 1,107/mm3 in chronic active cortical lesions, 25/mm3 in chronic inactive cortical lesions, 8/mm3 in myelinated MS cortex, and 1/mm3 in control cortex. In active and chronic active cortical lesions, activated microglia closely apposed and ensheathed apical dendrites, neurites, and neuronal perikarya. In addition, apoptotic neurons were increased significantly in demyelinated cortex compared to myelinated cortex. These data support the hypothesis that demyelination, axonal transection, dendritic transection, and apoptotic loss of neurons in the cerebral cortex contribute to neurological dysfunction in MS patients.

Citing Articles

Scaling up spatial transcriptomics for large-sized tissues: uncovering cellular-level tissue architecture beyond conventional platforms with iSCALE.

Schroeder A, Loth M, Luo C, Yao S, Yan H, Zhang D bioRxiv. 2025; .

PMID: 40060412 PMC: 11888418. DOI: 10.1101/2025.02.25.640190.


Astroglial modulation of synaptic function in the non-demyelinated cerebellar cortex is dependent on MyD88 signaling in a model of toxic demyelination.

Lohrberg M, Mortensen L, Thomas C, Fries F, van der Meer F, Gotz A J Neuroinflammation. 2025; 22(1):47.

PMID: 39988657 PMC: 11849172. DOI: 10.1186/s12974-025-03368-9.


Machine learning for refining interpretation of magnetic resonance imaging scans in the management of multiple sclerosis: a narrative review.

Szekely-Kohn A, Castellani M, M Espino D, Baronti L, Ahmed Z, Manifold W R Soc Open Sci. 2025; 12(1):241052.

PMID: 39845718 PMC: 11750376. DOI: 10.1098/rsos.241052.


Elevated BACE1 and IFNγ+ T Cells in Patients with Cognitive Impairment and the 5xFAD Mouse Model.

Zhan Y, Chen Z, Zheng S, Dai L, Zhang W, Dai Y ACS Chem Neurosci. 2025; 16(3):384-392.

PMID: 39810314 PMC: 11804866. DOI: 10.1021/acschemneuro.4c00565.


In vivo evidence for cell body loss in cortical lesions in people with multiple sclerosis.

Krijnen E, Lee H, Noteboom S, Chiang F, Steenwijk M, Schoonheim M Ann Clin Transl Neurol. 2024; 12(1):4-16.

PMID: 39673156 PMC: 11752088. DOI: 10.1002/acn3.52237.